Skip to main content
. 2017 Sep 12;11(9):e0005863. doi: 10.1371/journal.pntd.0005863

Fig 5. Age-specific prevalence of anti-Pgp3 antibodies in 1–9-year-old children, Kiritimati Island, Kiribati, November 2015.

Fig 5

Grey columns indicate the seroprevalence estimate for each one-year age band; red lines indicate 95% confidence intervals around those estimates.